NYSE · CIK 0001739104 · PHARMACEUTICAL PREPARATIONS
Elanco Animal Health Incorporated
ELAN chart by TradingView
PRICE HISTORY
LIVE · NYSEELAN chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $4.7B
- EBITDA
- —
- FREE CASH FLOW
- $0.3B
- EPS
- $-0.47
- GROSS MARGIN
- 54.99%
- ROIC
- -2.38%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 35 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
—
+31%14.0x277.9x
⤢
P / SALES (TTM)
2.5x
-30%1.0x4.4x
⤢
P / BOOK
1.9x
-8%0.6x2.4x
⤢
EV / EBITDA (TTM)
—
⤢
EV / REVENUE (TTM)
3.1x
-27%2.1x6.3x
⤢
FCF YIELD (TTM)
3.04%
-0.7pp-1.49%8.12%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$1.4B
+96%⤢
EBITDA (DERIVED)
—
⤢
NET INCOME
$0.1B
+$0.1B⤢
EPS (DILUTED)
$0.11
-57%⤢
REVENUE GROWTH YOY
10.23%
+10.9pp-25.03%118.26%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
17.84%
+15.9pp-13.44%24.34%
⤢
RETURN ON CAPITAL
-2.05%
-2.7pp-11.35%4.26%
⤢
RETURN ON EQUITY (TTM)
-3.02%
-4.0pp-21.50%6.41%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN58.33%
OPERATING MARGIN—
NET MARGIN3.95%
FCF MARGIN17.84%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.2B
+1606%⤢
STOCK-BASED COMP
$0.0B
+190%⤢
CAPITAL EXPENDITURE
$0.0B
+1%⤢
SHARES OUTSTANDING
0.51B
+72%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.5B
+54%⤢
TOTAL DEBT
$3.7B
+48%⤢
DEBT / EBITDA (TTM)
—
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 111.92%INSIDERS 1.22%OTHER / RETAIL 0.00%697 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Dodge & Cox Inc. | 13.80% | 68.9M | $1.53B | -12.8% |
| FMR, LLC | 10.19% | 50.9M | $1.13B | -2.4% |
| Blackrock Inc. | 9.53% | 47.6M | $1.05B | +2.8% |
| Primecap Management Company | 9.18% | 45.8M | $1.01B | -0.8% |
| T. Rowe Price Investment Management, Inc. | 6.93% | 34.6M | $766.1M | -1.7% |
| Dimensional Fund Advisors LP | 4.91% | 24.5M | $542.5M | -2.2% |
| Vanguard Portfolio Management LLC | 4.53% | 22.6M | $500.7M | NEW |
| Vanguard Capital Management LLC | 4.47% | 22.3M | $494.1M | NEW |
| State Street Corporation | 3.07% | 15.3M | $339.2M | +1.9% |
| Winslow Capital Management, LLC | 2.72% | 13.6M | $301.1M | NEW |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.